Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

NEMBUTAL

PENTOBARBITAL

Standard Dose
18.2MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEMBUTAL is listed in Drugs@FDA under application 083244 (ANDA).

Marketing status: Discontinued Active ingredient PENTOBARBITAL Form and strength ELIXIR;ORAL - 18.2MG/5ML Sponsor SCIEGEN PHARMS Submission history Latest submission status date: 1995-09-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEMBUTAL is listed in Drugs@FDA under application 083244 (ANDA). Marketing status: Discontinued Active ingredient PENTOBARBITAL Form and strength ELIXIR;ORAL - 18.2MG/5ML Sponsor SCIEGEN PHARMS Submission history Latest submission status date: 1995-09-20 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
NEMBUTAL (PENTOBARBITAL) | Drug Monograph | MedicHelpline